Home » Topics » BioWorld

BioWorld
RSS

CELL GENESYS GETS RIGHTS TO MOLECULE

June 29, 1992

CALGENE SEES GREEN IN ITS FUTURE

June 26, 1992

CALGENE TO REDEEM PREFERRED STOCK

June 26, 1992

CEPAHLON GETS PHASE II SBIR

June 26, 1992

QUADRA LOGIC FILES FOR OFFERING

June 26, 1992

MALARIA'S CHANGING GENES CHALLENGE RESEARCHERS

June 26, 1992

COURT SNUFFS PART OF NICOTINE PATCH SUIT

June 26, 1992

ONCOLYSIN M PURGES CANCER CELLS IN AML

June 25, 1992

T2 MEDICAL SHARES TAKE A BEATING

June 25, 1992

PHARMCHEM PLANS STOCK REPURCHASE

June 25, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...